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Abstract 
Background: Poverty and social deprivation have adverse effects on health outcomes and place a significant burden 
on healthcare systems. There are some actions that can be taken to tackle them from within healthcare institutions, 
but clinicians who seek to make frontline services more responsive to the social determinants of health and the social 
context of people’s lives can face a range of ethical challenges. We summarise and consider a case in which clini-
cians introduced a poverty screening initiative (PSI) into paediatric practice using the discourse and methodology of 
healthcare quality improvement (QI).
Discussion: Whilst suggesting that interventions like the PSI are a potentially valuable extension of clinical roles, 
which take advantage of the unique affordances of clinical settings, we argue that there is a tendency for such set-
tings to continuously reproduce a narrower set of norms. We illustrate how the framing of an initiative as QI can help 
legitimate and secure funding for practical efforts to help address social ends from within clinical service, but also 
how it can constrain and disguise the value of this work. A combination of methodological emphases within QI and 
managerialism within healthcare institutions leads to the prioritisation, often implicitly, of a limited set of aims and 
governing values for healthcare. This can act as an obstacle to a genuine broadening of the clinical agenda, reinforc-
ing norms of clinical practice that effectively push poverty ‘off limits.’ We set out the ethical dilemmas facing clinicians 
who seek to navigate this landscape in order to address poverty and the social determinants of health.
Conclusions: We suggest that reclaiming QI as a more deliberative tool that is sensitive to these ethical dilemmas 
can enable managers, clinicians and patients to pursue health-related values and ends, broadly conceived, as part of 
an expansive range of social and personal goods.
Keywords: Healthcare values, Healthcare quality, QI, Quality improvement, Social determinants of health, Poverty, 
Screening
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Background
Both primary and secondary healthcare predominantly 
treat and manage the downstream effects of social dep-
rivation, rather than tackling its upstream causes. This 
limits their ability to alleviate either social deprivation or 
its effects on population health and health services in the 
long term. Nonetheless, many healthcare professionals 
recognise the immense health and social burden of pov-
erty and social deprivation, and some are keen to harness 
the resources available to them in order to take effective 
action to tackle social deprivation and its contributions 
to health problems more directly from within healthcare 
institutions. This paper explores some of the ethical chal-
lenges facing clinical professionals who seek to expand 
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their clinical roles to address the social determinants of 
health.1
Our discussion draws on a case in which clinicians 
introduced a poverty screening initiative into paediatric 
practice using the discourse and methodology of health 
service quality improvement (QI). Clinicians paying 
attention to and doing something to help address social 
deprivation could be seen as a way of extending con-
ceptions of good quality care and strengthening service 
quality. But we argue that while using a QI frame can 
help legitimise interventions and secure funding, it can 
also constrain and disguise their value. We explore and 
illustrate how a combination of methodological empha-
ses within QI and managerialism within healthcare insti-
tutions leads to the prioritisation, often implicitly, of a 
limited set of aims and governing values for healthcare. 
These norms and values structure expectations about 
what it is that clinicians should be doing, and can act 
as an obstacle to a genuine broadening of the clinical 
agenda. They tend to reinforce norms of clinical practice 
which closely prescribe ‘health-related’ outcomes and 
effectively push poverty ‘off limits.’ We set out the ethi-
cal dilemmas facing clinicians who seek to navigate this 
landscape in order to address poverty and the social 
determinants of health. We suggest that reclaiming QI as 
a more deliberative tool that is sensitive to these ethical 
dilemmas can enable managers, clinicians and patients 
to pursue health-related values and ends, broadly con-
ceived, as part of an expansive range of social and per-
sonal goods.
Our discussion builds on, and to some extent maps 
onto, the well-trodden territory of value pluralism in 
healthcare, and in particular the tensions between differ-
ent values and goals in this domain. But our focus in this 
paper is not on resolving these tensions, or suggesting 
conditions for their resolution. Rather, we are interested 
in illustrating and analysing the normative complex-
ity that is generated when these tensions are negotiated 
in practice. Specifically, we consider the way that dif-
ferent values are reflected in and endorsed by the prac-
tices and actions of differently placed people—clinicians, 
patients, managers. We suggest that there is a tendency 
for a limited set of values to be continuously reproduced 
in clinical settings because of the literal and conceptual 
inaccessibility of certain objects of value to powerful 
actors.
Case study: poverty screening initiative
Our case study is a poverty screening initiative—hence-
forth PSI—developed in a paediatric assessment unit in a 
London (England) district general hospital. The PSI seeks 
to empower clinicians to be more attentive and respon-
sive to the social contexts of patients and their families, 
and to help them access resources and services locally. 
As a bottom-up initiative, spearheaded by clinicians, the 
PSI makes use of the resources and tools that clinicians 
have available to them, rather than attempting to enact 
high-level institutional change. The intervention com-
prises a short clinical screening survey and an informal 
referral process [4], reflecting recognition that ‘screen-
ing and referral’ is widely invoked and well-evidenced as 
an approach for front-line clinicians to contribute to the 
mitigation of social deprivation and poverty [5–12].
The PSI survey is completed by a patient’s parent or 
guardian while waiting to be seen, and given to their 
attending clinician. It includes questions about key mark-
ers of poverty and social deprivation, such as transport 
issues, housing insecurity, unhealthy and unsafe home 
environments, challenges procuring food and essen-
tials, and lack of emotional support. If any of the survey 
answers suggest cause for concern, clinicians are encour-
aged to initiate a conversation with the parent—during 
the consultation—about the patient and family’s personal 
and social circumstances. If appropriate, clinicians can 
provide parents with a leaflet and advice about access-
ing local resources and services aimed at increasing 
income and enabling access to essential goods and sup-
portive local community initiatives. These include debt 
and benefit advice services, grant-awarding organisa-
tions, food banks, voucher schemes for essential items, 
housing charities, domestic violence services, playgroups 
and support groups. The survey answers enable clini-
cians to tailor the conversation and advice to family cir-
cumstances. Patients and their families are not formally 
referred to local services or enrolled in relevant pro-
grammes—rather these resources are signposted to par-
ents, who can decide whether to initiate contact.
The PSI was developed by frontline clinical staff as a 
QI project. The clinicians who spearheaded the initia-
tive deliberately positioned the PSI as a QI project, fol-
lowed a QI methodology and evaluated its success using 
predefined measures in order to justify the project to 
their managers and colleagues. Without this QI fram-
ing they consider it very unlikely that the project would 
have secured institutional managerial permission to pro-
ceed. They also provided managers with evidence of the 
link between poverty and healthcare service use and the 
1 We recognise that being relatively socioeconomically disadvantaged can 
impact health and healthcare use regardless of poverty status [1, 2]. However, 
in practice, low socioeconomic status and poverty are coexistent. In London, 
where the case study intervention that we discuss was developed and imple-
mented, 39% of children live in relative poverty (in a household with income 
below 60% of the contemporary median) and 13% in material deprivation 
(unable to afford what are commonly regarded as essentials for life in the 
United Kingdom (UK)) [3].
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clinical benefits of screening and referral programmes, in 
order to justify the value of the project [10, 13–15].
QI projects typically seek to improve the quality of 
healthcare by measuring and evaluating current practice, 
and systematically introducing and evaluating interven-
tions designed to improve upon it. The PSI screening 
tool and referral process were devised and refined via a 
series of Plan-Do-Study-Act (PDSA) cycles—a structured 
approach to trialling and fine-tuning a change in practice 
in order to assess its impact [16]. Initially, potential ques-
tions and conversation-starters for the clinical encounter 
were proposed and discussed by staff in the paediatric 
assessment unit. Clinical staff were introduced by their 
peers to the initiative via multi-disciplinary teaching ses-
sions and a ‘how to ask about poverty’ guide was devel-
oped and circulated to all staff in the unit. A survey and 
resource leaflet were drafted, and subsequently tested 
and refined to ensure that they were appropriate, inof-
fensive, non-stigmatising and acceptable to both patients 
and clinicians. Consistent with the QI approach, the suc-
cess of the PSI was formally assessed—in this case via a 
series of process and outcome measures: percentage of 
doctors who screened for child poverty; percentage of 
doctors aware of local resources for children and fami-
lies living in poverty; number of poverty resource leaflets 
given per shift; and patient feedback [4]. Longer-term 
outcome measures were not captured.
The PSI intervention has gained momentum and 
spread quickly to other sites in London, including com-
munity services and other acute services. On the whole 
it has been spread by word of mouth and championed 
locally by clinicians, indicating that it feels both practi-
cable and worthwhile to staff on the ground. Qualitative 
feedback from staff and patients reinforces this reading 
[17]. We are not seeking to further review or evaluate the 
success of the PSI here. Rather we are using it as a case 
study to analyse the affordances and constraints of clini-
cal settings for attending to patients’ social contexts and 
experiences. In particular, we are interested in the ways 
that the architecture and language of healthcare quality 
and QI enable and constrain the promotion of different 
kinds of ends and values, and the choices and compro-
mises clinicians have to make in order to navigate this 
domain.
We intend our arguments to have relevance outside of 
the English context, but our analysis of the case inevi-
tably reflects the values and operation of the system 
within which the PSI sits. QI has a high profile and is 
well embedded in the English NHS. The long-term plan 
published in 2019 by NHS England and NHS Improve-
ment—the body that leads the English NHS—has the 
improvement of care quality and outcomes over the 
following 10  years as one of its core goals [18]. NHS 
England and NHS Improvement also has a track record 
of building workforce capability and offering advice and 
training in QI methodologies. National quality initiatives 
include ‘Quality Accounts’—an indicator-focussed report 
that every provider of NHS healthcare services in Eng-
land must publish annually—and ‘best practice tariffs, a 
quality-based payment system, with differential tariffs for 
hospital admissions depending on the quality of care pro-
vided [19, 20]. QI activity on the ground is uneven but 
commonplace and, although a range of QI approaches 
are practised, the Institute for Healthcare Improvement’s 
Model for Improvement—which uses the kind of PDSA 
cycles adopted in the PSI—has been particularly influ-
ential [21]. The conceptualisation of healthcare quality 
at the level of hospital management in England empha-
sises external factors, such as quantifiable indicators 
and national targets, and focuses on clinical measures 
of quality, suggesting a ‘managerial approach’ [22]. In 
recent years, attempts have been made to integrate health 
and social care—in 2018 the Department of Health was 
rebranded the Department of Health and Social Care—
but over the past decades, attempts to tackle health ine-
qualities via ‘joined-up government’ have struggled to 
overcome siloed units, and divergent priorities and tar-
gets [23].
The case study presented here takes the form of an 
ethical argument rather than a formal data-generating 
piece of empirical bioethics. However, in constructing 
our argument we sought to achieve some of the spirit and 
advantages of empirically informed work, and it is worth 
briefly elucidating the approach we took. One of the 
authors (GS) was the prime mover behind the PSI and 
simultaneously worked with the other authors to analyse 
some of the ethical issues arising from this QI initiative. 
This collaboration provided an extra dimension of profes-
sional and theoretical reflexivity on the initiative, in addi-
tion to the qualitative evaluation built into it. The process 
involved a series of four roundtable discussions in which 
the co-authors considered the genesis, enactment, expe-
riences and challenges of the PSI. These discussions were 
informed by the first-hand reflections of the principal 
actor and reported accounts from other participants 
and stakeholders, as well as by the PSI documentation 
and evaluation paperwork. Between roundtable meet-
ings authors shared notes and sketches of possible argu-
ments for consideration, and began to identify analogous 
issues and themes in the broader literature. This process 
allowed for considerable back and forth between engage-
ment with the concrete details of the initiative and the 
developing theoretical and literature-based analysis. It 
also generated the key themes reviewed in what follows—
notably the tensions that arise both at the interface of the 
clinical and public health functions of healthcare services 
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and between more managerial and deliberative models of 
QI.
Discussion
Addressing poverty within clinical practice
Before turning to these questions about the normative 
‘architecture’ of healthcare quality, we think it is impor-
tant to respond to potentially sceptical voices arguing 
that addressing poverty should simply fall outside the 
domain of clinical roles and ethics. We will stop short 
of arguing that there is a professional obligation for cli-
nicians to address poverty, but we would argue that 
addressing social deprivation is of clear ethical relevance 
to clinicians and that there is also a prima facie legitimacy 
in clinicians exploring the specific contributions they can 
make in this area because of the distinctive affordances of 
clinical settings.
Poverty is obviously a challenge for those who experi-
ence it, powerfully undermining their personal and social 
lives. But it is also a considerable challenge for health 
services. Increased social deprivation is associated with 
higher rates of primary care consultation, higher num-
bers of medical referrals, and more emergency and psy-
chiatric hospital admissions [14, 24]. The most deprived 
people are far more likely to be admitted to hospital over 
their lifetimes compared to the most affluent, with signif-
icantly greater associated lifetime costs despite lower life 
expectancy [13]. Formal health promotion and preventa-
tive services have some potential to moderate the adverse 
health implications of poverty on individuals and health 
services. However, uptake and impact rates of services 
such as cardiovascular checks, childhood immunisation 
and screening programmes are often lower in socially 
deprived groups, and the most deprived people may be 
less able to follow standard medical advice about healthy 
lifestyles [24, 25]. This can mean that potential health 
benefits are not realised, and social inequalities in health 
can even be exacerbated.
It is thus understandable that those frontline clini-
cians who are conscious about the social determinants 
of health can be motivated to use their knowledge and 
positioning to make a contribution to addressing the eve-
ryday challenges that their patients face. But it might be 
argued that addressing the social determinants of health 
is simply not a clinical responsibility. Some conservative 
voices, for example, might argue that clinicians—espe-
cially hospital-based clinicians such as those who devel-
oped the PSI—should concentrate their energies on those 
biomedical concerns for which they have specialised 
expertise and dedicated resources.2 Alternatively it might 
be argued by more progressive voices that engagement in 
such agendas is important and something doctors should 
embrace as citizens but in ways that effectively fall out-
side the clinical sphere, for example, through the exercise 
of political voice and lobbying in partnership with a range 
of other agencies and movements.
However, it is worth highlighting that frontline clini-
cians and clinical settings are in some ways peculiarly 
well suited to identifying markers of poverty and offer-
ing advice to patients [26]. Clinical relationships them-
selves have affordances that are relatively rare. There are 
established conventions and expectations that make it 
possible for clinicians to ask questions about a patient’s 
personal and social history and to offer help and advice, 
albeit within limits and recognising potential ethical con-
cerns about invasiveness. An intervention such as PSI 
takes advantage of this fact. Its format and application 
as a familiar universal and ‘neutral’ screening tool helps 
to make it acceptable to clinicians and patients. Patients 
are familiar with being asked to fill in forms in the wait-
ing room prior to their consultation, to be handed over 
to their attending clinician. Clinicians are familiar with 
quickly evaluating such forms and using them to direct 
and shape the clinical encounter. While there is some-
thing quite dispassionate and impersonal about filling in 
a form, the survey creates opportunities for deeply per-
sonal and potentially emotionally charged conversations. 
The tool enables the patient and their healthcare profes-
sional to share information in a way which ‘breaks the 
ice’ with respect to topics and issues that it might oth-
erwise be socially awkward to raise. The tool itself, then, 
takes some of the impassive conventions of the collection 
of information within the context of clinical consulta-
tions, and uses this as a prompt for conversations which 
go beyond the normal content and scope of healthcare 
practice. It provides, then, a ‘peg’ on which to hang top-
ics for discussion which are typically excluded from this 
space and, by so doing, allows a different set of values to 
be embodied in and promoted by the healthcare encoun-
ter—reflecting, for instance, a wider conception of health 
and different goals of healthcare.
The issues raised by the PSI and the questions and con-
versations to which it is intended to give rise may touch 
on topics which are rarely publicly broached—even with 
close friends and family members—such as income, 
financial security, and domestic violence. However, clini-
cal spaces already carry the expectation that personal 
information will be discussed openly and confidentially. 
Discussions, topics and actions which might be ethically 
or emotionally risky in other contexts—asking some-
one to undress, touching their body, asking them about 
their sexual activity, alcohol intake, and diet—are in some 
respects made possible and safe within the context of 
2 Primary healthcare in the UK has historically included public health per-
spectives and sought to address social concerns more readily than secondary 
healthcare, so such critique might be more likely to occur in secondary than 
primary care settings.
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clinical encounters. The anomalous conventions of the 
clinical encounter mean that, perhaps paradoxically, con-
versations about poverty and social deprivation in clini-
cal contexts may be experienced as less threatening or 
stigmatising compared to analogous conversations being 
initiated in non-clinical contexts.
Of course, by the same token, the clinical setting and 
the design of the tool may render the resulting exchanges 
and relationships less flexible than is desirable. A patient’s 
expectation that clinical consultations will be chiefly 
concerned with their biomedical health might pre-
vent them from feeling able to talk as freely about their 
domestic and financial circumstances with a clinician as 
they would with a social worker, for instance. However, 
for those people who live in poverty but are not deemed 
vulnerable enough to warrant their having a social 
worker—potentially a large number in times character-
ised by recession, economic stagnation and funding cuts 
to core social services—clinical encounters may be one 
of their only opportunities to discuss these topics with 
an informed professional. Interventions like the PSI may 
create objects of value for clinicians and patients in con-
strained circumstances, without these being ideal or opti-
mally valuable. The use of a survey with a predetermined 
set of questions might constrain what both patients and 
clinicians deem relevant to or part of the social deter-
minants of health. But the clinicians who developed the 
initiative saw the survey as a starting point for a conver-
sation rather than a technical or exhaustive assessment 
of the social determinants of health. For these reasons 
interventions such as the PSI can plausibly be presented 
as ethically defensible utilisations and extensions of the 
clinical role, with the potential to support other public 
health initiatives which aim to relieve poverty.
Valuing healthcare interventions
For the clinicians involved, the framing of the PSI as a 
quality improvement initiative was central to efforts to 
secure its perceived legitimacy. ‘Quality’ is a relatively 
open-ended and contested concept which, even on 
standard accounts, accommodates multiple dimensions 
(including equity and patient-centredness) [27, 28]. This 
makes a QI framing elastic enough to support a diver-
sity of goods, values and aims in healthcare. However, in 
practice, the costs and benefits of interventions are not 
only very diverse in nature, but also differently under-
stood and prioritised by differently placed actors. In this 
section, while acknowledging how using a QI frame can 
enable the pursuit of better healthcare, we draw out some 
of the complexities inherent in appeals to quality. We 
highlight the challenges of valuing the costs and benefits 
of healthcare interventions including the perspectival 
character of these valuations—the fact that different peo-
ple value different goods and ends differently.
The costs and benefits of healthcare intervention
Interventions like the PSI have a range of foresee-
able costs and benefits for different actors. If success-
ful, patients experiencing the challenges of poverty will 
receive information about local resources and be able to 
access and use them. This will potentially lead to bene-
fits such as increased income and household resources, 
safer and more healthy home environments, better 
emotional support, higher well-being and lower stress 
levels. These might lead to better health and healthcare 
outcomes for patients and their families, which, in turn, 
could lead to decreased or more effective use of health-
care services—reducing the burden on either the paedi-
atric assessment unit or other parts of the system. This 
causal pathway is by no means a straightforward one, but 
research into the social determinants of health suggests 
it is at least possible [29]. There may also be more proxi-
mal benefits associated with the intervention—open and 
honest discussions between parents and clinicians about 
poverty might help to build trust and good communica-
tion—which can also plausibly contribute to the safety 
and effectiveness of healthcare. Recognition of the fact 
that patients and their families are living in difficult and 
unsafe circumstances, the impact of social deprivation on 
their health, and the genuine difficulties in following ideal 
professional advice about diet, healthy lifestyle and medi-
cation management could help parents to feel ‘seen’ and 
valued. This is particularly salient when past experience 
has left parents feeling vulnerable to unwarranted profes-
sional assumptions that they do not care or are incapable 
of caring well for their children [30, 31]. Moreover, the 
initiative could be beneficial for the health professionals 
implementing it. Many clinicians care deeply about pov-
erty and inequality, and the opportunity to develop and 
administer an intervention to address something they 
deem important has the potential to mitigate burnout 
and improve well-being [32–34]. These proximal ben-
efits might also lead to future clinical benefits but, even if 
they don’t, they can be understood to be positive ends in 
themselves.
But developing and implementing interventions like 
the PSI will also have significant time and resource 
implications, and so carries opportunity costs. During 
development, discussing the PSI intervention in multi-
disciplinary meetings used time which clinicians could 
have spent on other projects or priorities. The interven-
tion itself requires clinicians to spend time during their 
consultations with patients discussing their social and 
family circumstances, time which could otherwise be 
spent focussing more directly on clinical ends, or which 
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could be used to fit in more patient appointments over-
all. Increased referrals have the potential to drive up 
costs and the overall resource burden for local charities 
and state-funded welfare services, even if they end up 
decreasing the burden on the healthcare system.
Determining the all-things-considered value of an 
intervention like the PSI includes determining whether 
its benefits outweigh its costs. This is by no means a 
straightforward matter. Measuring the benefits and costs 
may be very difficult, particularly if they are subjective 
goods (such as well-being and trust) or accrue to diverse 
parts of the healthcare system or other ‘non-health’ insti-
tutions. Moreover, even if they can be adequately meas-
ured, it remains very unclear how to compare costs and 
benefits of very different kinds and to weigh up their rela-
tive value.
The value of using a QI frame
Complex ethical trade-offs and challenges relating to 
appropriate measurement and comparison are unavoid-
able features of any intervention intended to change, 
and ultimately to improve, healthcare practice. Treating 
the PSI or another intervention as a QI initiative is one 
way of acknowledging and managing such trade-offs. 
Using a QI frame signals that the costs and benefits of 
a project are being considered, and to some degree sys-
tematically identified and measured. Ideally, this allows 
decision-makers to make judgements about whether 
an intervention really amounts to an improvement all 
things considered, and to determine whether it should 
be continued or extended. In practice, even with very 
imperfect information, a QI frame means that decision-
makers can be seen to be mindful of the need to system-
atically monitor initiatives and to balance competing 
considerations. Systematic measurement and evaluation 
of interventions does not, of course, solve all the poten-
tial problems with comparing different kinds of costs and 
benefits, but it does endeavour to make such compari-
sons well-evidenced.
In principle, QI can accommodate a wide variety of 
ends: it need not only consider financial costs and ben-
efits, but also changes in, for example, clinical outcomes, 
patient experience and fairness. Accounts of healthcare 
quality tend to be relatively broad and recognise diverse 
ends. The definition of what counts as good healthcare, 
or as an improvement, can be multi-dimensional, com-
prising various different, including incommensurable, 
goods. It can also be flexible, with different accounts of 
healthcare quality, or different emphases, being used or 
combined in different contexts [28]. Of course identify-
ing and measuring a variety of goods and ends does not 
in itself generate an answer as to whether an intervention 
is beneficial, all things considered—assessing the value of 
an intervention always involves making evaluative judge-
ments, which reflect the relative priority of different costs 
and benefits.
In short, QI provides a language for legitimising and 
justifying healthcare decisions. By requiring practition-
ers to explicitly identify the aims of an intervention, QI 
approaches can help to make the reasoning behind deci-
sions about resource distribution and priority setting 
transparent. By insisting on considered development and 
implementation of measures, QI approaches can ensure 
that variables are measured consistently over time, allow-
ing for meaningful assessment of change and the impact 
of interventions. For these reasons, QI has acquired high 
status within healthcare as a source of evidence about 
good practice. Designing and implementing an interven-
tion as a QI project can thus enable healthcare profes-
sionals seeking to enact something that they reasonably 
believe will be beneficial for their patients or for their 
healthcare practice in some respect. Styling an interven-
tion as a QI project can open up funding and resources 
which might otherwise be unavailable, both from within 
healthcare institutions and from national grant-awarding 
organisations. It can also increase a project’s priority 
status, justifying staff spending time in meetings and on 
administrative tasks, and changes to patient pathways or 
clinician roles.
Perspective and healthcare values
Although QI can, in principle, accommodate a diverse 
set of values there is further complexity in the way that 
different values and aims are recognised, appraised and 
pursued in healthcare. Different goods are valued and 
prioritised differently by different actors, depending on 
how they are positioned with respect to the healthcare 
system, their role and responsibilities, and their interests.
Those responsible for budgets and resource man-
agement within healthcare institutions operate within 
institutional and budgetary constraints and have respon-
sibilities for values that are recognisable to and measur-
able by the institution, such as clinical effectiveness and 
financial efficiency. There are more-or-less well-defined 
activities that these professional actors are expected and 
required to carry out, and more-or-less well-defined 
financial resources for those activities. As such, some ser-
vices and outcomes will be clearly within their remit, and 
so denoted ‘health-related,’ and others less so, or not at 
all so. It was for this reason that the clinicians develop-
ing the PSI justified the project to managers via evidence 
about the ability of poverty screening and informal refer-
ral interventions to reduce readmissions and burden on 
their services and generate improved clinical outcomes. 
Indications that the intervention could improve quality in 
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this respect were seen as central to its perceived legiti-
macy by managers.
But distinctions between ‘health-related’ and ‘non-
health-related’ outcomes are likely to be far less, if at 
all, salient for patients, who are not incentivised to draw 
boundaries between the remit and goals of different pub-
lic institutions in the same way that professionals are. 
From the perspective of patients and families, the success 
of the PSI need not depend on it reducing the resource 
burden on the healthcare system, let alone a particular 
part of it, nor need it necessarily depend on its having 
health-specific personal benefits. While better health and 
fewer hospital readmissions or healthcare visits may very 
well be perceived as good outcomes by patients and fami-
lies, they are not the only or primary things of value that 
patients and families stand to gain from engaging with 
local resources designed to help alleviate poverty and 
social deprivation. As mentioned above, the PSI might 
lead to better relationships with healthcare professionals, 
but also better well-being and more goods and resources 
in a broader sense: less stress and worry, more financial 
and welfare support, more household resources, stronger 
social networks, and reduced threat of domestic abuse. 
There is little reason for patients to distinguish cleanly 
between health-related and non-health-related benefits: 
they are more likely to be concerned with the ability of 
the system to sensitively and holistically support them in 
providing for themselves and their families, and respond 
to their needs such that services benefit them in ways 
which matter to them.
The paediatric clinicians who developed and adminis-
tered the PSI sit between these two poles. Their profes-
sional identities are substantially shaped by the secondary 
healthcare institutions within which they work, and their 
personal aims and values are liable to be at least partly 
aligned with institutional ones. Although, in principle, all 
clinicians have some public health facing responsibilities 
and also need to be mindful of patient well-being and not 
simply biomedical outcomes [35], these broader concerns 
are only sometimes made institutionally explicit in pop-
ulation health remits or hybrid roles. Nonetheless, the 
legitimacy and value of the PSI for clinicians is not just 
grounded in the clinical and cost-effectiveness measures 
which concern their managers. The clinicians involved 
in the project recognise that many of their patients live 
in poverty, which causes, and has the potential to cause 
substantial, persistent ill effects on their health and well-
being. As long as efforts focus on treating only the health 
effects of social deprivation, rather than the underlying 
or intermediating causes, their impact will be limited, 
given continued adverse background conditions. Health-
care professionals may even feel or appear complicit in a 
plastering over of deep social injustice.
For clinicians, a large part of the value of interven-
tions like the PSI is that they provide an opportunity 
to use their relative knowledge and status to positively 
impact these underlying causal factors. The success 
of this does not depend on particular benefits accru-
ing to their part of the healthcare system, or indeed to 
the healthcare system at all. Rather, it depends on the 
intervention producing some tangible benefit for their 
patients and their families. Moreover, clinicians have an 
interest in developing and maintaining open commu-
nication and a trusting relationship with their patients. 
Recognising the fact and burden of social deprivation 
and its widespread and harmful effects, and creating a 
space for it to be openly discussed within the context 
of the clinical encounter, could be instrumental in cre-
ating and sustaining such a relationship. Again, while 
good communication might lead to identifiable health 
benefits, these do not exhaust its value.
This exploration of the different values and benefits 
which healthcare—and different actors within it—can 
aim at and produce raises a number of familiar ethical 
tensions. It emphasises the competing goals of health-
care—including at institutional, biomedical, personal 
and population levels—which cannot always all be pur-
sued or prioritised at once. Related tensions may also 
emerge between different ways of conceiving of the 
definition and value of health—whether in more tech-
nical biomedical terms or in more explicitly normative 
terms, factoring in the psychosocial well-being and 
personal aims of individual patients and communities. 
In addition, our account highlights that clinicians may 
have competing obligations—to their institutions, to 
patients, to their profession—which can pull in differ-
ent directions.
While we recognise the importance of these tensions 
and they underpin our discussion, they are not our 
direct focus in this paper. Rather, our focus is on the 
way these tensions are indirectly managed as well as 
consciously negotiated through the use of quality dis-
courses. More specifically in the remainder of the paper 
we argue that a QI framing combined with the power 
invested in healthcare managers as decision-makers, 
can lead to a limited set of institutional values being 
implicitly prioritised and built into healthcare decision-
making. There are clear tensions facing professionals 
who want to help tackle social deprivation whilst based 
in clinical settings. Specifically, neither the pursuit 
of population health nor support for non-biomedical 
social goods are consistently incentivised by healthcare 
institutions in England, especially in secondary care. 
They may often even be disincentivised, when work is 
oriented around localised benefits and outcomes that 
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are defined in biomedical and institutional terms, rather 
than broader social and personal goods.3 This leaves 
professionals who want to help tackle social depriva-
tion from within clinical settings facing dilemmas. One 
way to avoid this unfortunate constriction of healthcare 
values is, we will suggest, by embracing a more explicit 
and expansive value pluralism in healthcare decision-
making. This might involve becoming comfortable with 
irresolvable tensions between values, as well as recog-
nising that not all benefits are readily measurable and 
that  cost–benefit analysis can rarely provide a clear 
solution which is not also deeply value-laden.
QI and the constraint of healthcare value
In this section, we argue that, as well as accommodat-
ing and enabling an expansive set of healthcare values, 
quality discourses can also constrain and disguise health-
care values in significant ways. In theory, definitions of 
‘healthcare quality’ can be relatively open-ended but, in 
practice, quality discourses are likely to be much more 
circumscribed because they are shaped by specific insti-
tutional norms and priorities. QI, when used within an 
institutional framework for analysing the value of health-
care, will tend to prioritise certain goods and values 
over others, and to prioritise a particular, institutional, 
perspective. This makes it difficult to use a QI frame to 
adequately evaluate interventions, and can make it a 
powerful constraint on the aims and values that are pur-
sued in healthcare. In particular, it can make it difficult 
to recognise and pursue wider social ends such as the 
relief of poverty and more intimate personal ends such 
as interpersonal relationships that are characterised by 
good communication and trust, and values like personal 
well-being, which are not ‘health-related’ in a restricted, 
institutional sense.
As noted above, quality discourses are potentially both 
broad and diverse. This expansiveness is valuable for 
purposes such as policy debate, system redesign or pro-
fessional education and reform. Here there is scope not 
only to take seriously recognised dimensions of clinical 
healthcare quality that are sometimes neglected, such as 
person-centredness and equity, but also to utilise broader 
constructions of quality in public services including 
extra-clinical concerns related to personal and com-
munity well-being, or draw upon applications of qual-
ity discourses to public health practice [37]. However, 
it is inherently problematic to retain this expansiveness 
within QI practices, both because of the general demands 
of operationalisation and, more specifically, because of 
pressures from health service managerialism. QI is, as 
signalled above, largely a technical activity that depends 
on the operationalisation of quality concepts. In order 
to specify, plan, monitor and evaluate desired ‘improve-
ments’ QI teams need to identify key indicators of pro-
gress. This technical emphasis is also typically embedded 
within the models and methods of QI which, for the most 
part, derive from industrial models of production [38]. 
The result is that the concern with systematisation and 
measurement in QI practice will always tend to close 
down the potential open-endedness of, and contestations 
of values within, quality discourses.
This is especially the case when QI sticks closely to the 
simplifying and unifying technicist logic of operational-
ised decision-making. It is highly improbable that there 
could be a coherent and practicable conception of health-
care quality that holds together the range of things that 
matter to all the differently placed actors whose interests 
are relevant to a project like the PSI. Not only must such 
a conception capture the aims and values of clinical insti-
tutions, but also those which characterise clinical rela-
tionships and underpin personal, family and community 
well-being. Such a conception of quality would have to 
weigh up a large number of objects of value which are 
incommensurable along a variety of different dimensions. 
For instance, some of them accrue to individuals, some to 
populations or groups of individuals, and some to insti-
tutions; some of them are objects of health related value 
and others are objects of social value more broadly; some 
of them are easily measured and others are not, or their 
measurement is deeply contested; some of them are only 
visible to and identifiable as valuable by people occupy-
ing a particular perspective. Weighing up incommensu-
rable values to come to a single assessment of healthcare 
quality is difficult enough when the values are determi-
nate, few, and constrained in scope. When the values are 
indeterminate, diverse and numerous, clear, accountable 
decision-making starts to look impossible.
We have, perhaps, painted an unduly narrow picture 
of QI and its potential to represent complexity. The 
field of QI has arguably been steadily evolving so as to 
narrow the gap between the elasticity of quality and the 
relative closure of QI models. QI has long had an inter-
est in the use of ‘balancing measures’—additional indi-
cators that pick up concerns beyond the key measures 
of success [39]. This degree of flexibility and responsive-
ness has now been supplemented by an interest in the 
3 Even institutions with an ostensible public health remit may be limited in 
their ability to effectively address the social determinants of health. For exam-
ple, the ‘Quality Outcomes Framework’ (QOF)—a voluntary incentive pro-
gramme for primary care organisations in England, which offers financial 
rewards for good practice—has a public health domain. However, QOF largely 
incentivises data collection (e.g. recording patients on disease registers), pre-
scription of primary prevention medication (e.g. statins for patients with a 
new diagnosis of hypertension or type 2 diabetes), and behaviour change pro-
grammes (e.g. smoking cessation support) rather than interventions which 
address the underlying causes of these behaviours and health states [36].
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‘co-production’ of success criteria (as well as improve-
ment processes) [40, 41]; a recognition of the impor-
tance of ‘soft intelligence’ and not just quantitative 
measurement in evaluation [42]; and more fundamental 
calls for the incorporation of pluralistic thinking within 
QI cultures [28, 43, 44]. All of these suggest directions 
for and cultures of QI that could combine technical 
with deliberative and participatory elements. They rep-
resent a critical, reforming current in QI, which has 
the potential to capture some of the ambitions of the 
clinical advocates of the PSI and the multiple, compet-
ing conceptions of success we have rehearsed, whilst 
at the same time acknowledging related trade-offs and 
incommensurabilities. One central element to a more 
pluralistic approach to QI is the idea that healthcare 
decision-makers should allow themselves to be more 
comfortable with unresolved incommensurability, that 
is, with evidence that does not in itself suggest a single, 
clear solution, where different goods and values pull in 
different directions. Legitimate decision-making, on 
such an approach, involves making explicitly normative 
evaluations which draw on and interpret a variety of 
different kinds of evidence, rather than supposing that 
solutions can be read directly off available data. In turn, 
QI practice could itself potentially evolve to reflect a 
greater degree of value pluralism, if it is actively shaped 
by communities oriented towards research or profes-
sion building—including those professional commu-
nities who helped develop the PSI. In short, this shift 
in a more deliberative direction would entail ‘opening 
up’ and self-consciously addressing the ethical con-
tests that are inherent in the process of making quality 
judgements [45].
Having said this, the demands of QI within health ser-
vices—especially those dominated by managerial cur-
rents, as seen in the English context—are liable to obscure 
or even obstruct overt engagement with value pluralism. 
In the real-world context within which the PSI was devel-
oped and is applied, the justification of the project via a 
QI methodology primarily means satisfying institutional 
and managerial concerns about cost efficiency and clini-
cal effectiveness. Other concerns, such as broader social 
benefits or objects of personal and relational value are 
thereby side-lined. Although a QI methodology could 
prioritise non-managerial concerns, in practice this is 
unlikely to happen without a fundamental shift in the 
way that QI is used as a tool in healthcare. More holis-
tic, ‘systems approaches’ to QI have been employed, with 
success, in the context of Indigenous healthcare provi-
sion, where community engagement and cross-sector 
working is imperative, and where there is a pressing need 
to address social determinants of health [46–48]. Such 
efforts have involved substantial changes in policy and 
healthcare infrastructure, which underpin participatory 
approaches to QI with genuine decision-making power 
with respect to healthcare delivery and evaluation.
One reason for the tendency to prioritise institutional 
and managerial concerns is simply that the institution-
ally defined priorities of those who occupy positions of 
power with respect to decision-making about resource 
allocation in healthcare settings are liable to shape how 
those decisions are made. QI can thus become a chiefly 
managerial tool, aimed at shaping and coordinating the 
behaviour of individuals to produce certain kinds of out-
comes. In these circumstances it is used as part of efforts 
to take a ‘high level’ perspective, and to enact change 
and pursue defined ends and values at a system level. Of 
course, managers may also have other motivations and 
will usually have an interest in staff feeling effective and 
valued, and so will be to some extent concerned to reflect 
the priorities and values of clinicians in their resource-
allocation decisions. But they also have strong incen-
tives to prioritise some ends over others where these are 
specified in their role descriptions and personal perfor-
mance indicators, partly because of the personal benefits 
and costs associated with these, such as salary, promo-
tion, status, positive and negative working relationships, 
disciplinary action, dismissal, and so on. Of course, it 
is important to acknowledge that managerial concerns 
should not simply be dismissed as distortions of what 
matters: they represent values, priorities and norms in 
which institutions have a legitimate interest. But they are 
certainly not thereby the only or even the primary con-
cerns that should shape institutional aims and priorities 
more broadly.
So while QI can act as an enabler to healthcare inter-
ventions, providing a language in which they may be 
justified and legitimated, the architecture and methodol-
ogy of QI can also constrain them by prioritising certain 
kinds of values and ends, and the values and ends of par-
ticular actors and institutions, in that justification.
Dilemmas for clinicians and value currency conversion
Clinicians who believe they have an ethical responsi-
bility to respond to the social contexts of health and to 
act so as to alleviate the effects of poverty face a num-
ber of challenges. At the start of the paper we argued 
that clinical settings and relationships have affordances 
which mean clinicians might be able to make impor-
tant contributions, some of which are less open to, or 
feasible for, others. If clinicians are motivated by popu-
lation health and well-being, and perhaps even influ-
enced by accounts of ‘quality in public health,’ they 
will start from the assumption that preventing the ill-
health consequences of poverty is a ‘shared responsibil-
ity’ that entails targeting services to reduce inequalities 
Page 10 of 13Mitchell et al. BMC Med Ethics           (2021) 22:91 
and embedding this agenda system-wide so that it runs 
across all public policy [37]. They might reasonably 
think it ironic if this agenda should apply everywhere 
else in society but somehow not within health services 
themselves. And yet these larger societal ends are not 
typically recognised or incentivised within health ser-
vice structures, so promoting them involves converting 
them into different value currencies. That is, it involves 
describing what is good about them in terms which 
can be better accepted and managed within existing 
cost–benefit and decision-making frameworks within 
healthcare services. This conversion is not without loss, 
however, and involves clinicians engaging in pragmatic 
compromises in order to pursue the things they con-
sider valuable.
In order to promote the pursuit of ends such as the 
tackling of poverty, clinicians may have to effectively 
smuggle them in under different flags. In the case of the 
PSI, for example, this involved describing the benefits 
of the intervention in terms that would be accepted in 
managerial decision-making as within the institution’s 
remit, even though these did not represent clinicians’ pri-
mary motivation for developing the project, and were not 
perceived by clinicians to be the most valuable expected 
benefits. The use of a QI framing to justify and legiti-
mate the PSI makes the project something of a Trojan 
horse—its true motivation is, at least in certain contexts, 
disguised or downplayed in order to ensure its smooth 
passage. Such subversiveness enables the pursuit of val-
ued ends which are not adequately recognised or priori-
tised in managerial decision-making.
The same is arguably also true with respect to the more 
interpersonal benefits generated by interventions such as 
the PSI—their potential to improve communication and 
trust, and enrich clinical relationships. These plausibly 
have institutional benefits, insofar as the better clinical 
relationships have the potential to inform better clini-
cal decision-making, but their value is not exhausted by 
these. It may be difficult or impossible for service qual-
ity radar to recognise inherent value of trust and good 
clinical relationships, though these are often tangible to 
clinicians and patients. These benefits are more difficult 
to measure, subjective, and less easy to observe, as they 
typically arise during clinical encounters and depend on 
the perspectives and interactions of the particular par-
ties. These personal and interpersonal benefits are, like 
broader social benefits, unsuited to being counted as 
benefits for managerial decision-making because they are 
what we might call ‘metrically intangible’ at the mana-
gerial level. Broader social benefits are intangible at the 
managerial level because they fall outside of the scope of 
defined institutional practice, and personal benefits are 
intangible because they are difficult to identify, measure 
and understand from a more removed or ‘objective’ 
perspective.
The metrical intangibility at the managerial level of 
goods considered valuable by clinicians means that in 
order to get a project like the PSI accepted, clinicians 
have to navigate different value currencies, and make 
pragmatic adjustments and compromises. On the one 
hand, if they place too much emphasis on metrically 
intangible interpersonal and social goods, their initia-
tives are unlikely to gain credibility, or even a foothold, in 
health services, because their value will likely not be rec-
ognised by those who hold the purse strings. Re-describ-
ing the value of interventions like the PSI in managerial 
terms enables them to happen at all and so to produce 
the goods which clinicians and patients value—even 
though these are not necessarily the reasons why they 
have been prioritised. But, on the other hand, if clinicians 
place too much emphasis on currencies of efficiency 
linked to measurable health outcomes, they risk not only 
measuring the wrong thing, and setting themselves up to 
fail, but distorting the intervention to such an extent that 
it loses its point.
If the value of an intervention like the PSI lies in the 
personal and social benefits that it is liable to produce, 
and it does not produce significant or measurable man-
agerial health service benefits, then a QI framing which 
focuses on managerial benefits is unlikely to judge the 
intervention successful. Converting the value of the 
intervention into a managerial value currency thus risks 
failing to showcase its actual benefits. However, even if 
an intervention that seeks to positively impact on poverty 
and social deprivation does generate managerially rec-
ognised benefits, describing its value in terms of its effi-
ciency and effectiveness with respect to narrowly defined 
clinical and financial ends that are internal to a given 
health service risks undermining the point of the inter-
vention. For if an initiative is appraised and funded on the 
basis of its system-level efficiencies, the social benefits it 
produces outside of the system will always be secondary 
to internal managerial goods. Such external benefits will 
be tolerated so long as they accompany internal benefits 
of managerial value, but they will not be valued in their 
own right. At the extreme, this might mean that the miti-
gation of poverty is no longer properly understood to be 
a de facto end of an initiative like the PSI.
This suggests that clinicians who develop projects using 
QI methodology which seek to promote broader social 
goods face some difficult dilemmas. They need to align 
to managerial ends to enough of an extent that their pro-
jects are authorised, but at the same time ensure they do 
not lose sight of the personal and social benefits of inter-
vention. As well as the potential short-term costs of los-
ing sight of these ends—that is, they end up not being 
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optimised or promoted by the intervention—there are 
also potential long-term costs. By fully aligning to mana-
gerial ends, there is a risk that clinicians undermine the 
prospects of their own ends being recognised as valuable 
in the longer term. Failure to promote and publicise the 
objects of value that are not straightforwardly metrically 
tangible to their institutions risks further compounding 
their perceived irrelevance or relative unimportance.
Conclusions
We have argued that limited constructions of clini-
cal professional roles and ethics risk being reproduced 
by healthcare institutions. In particular we have high-
lighted the potential for quality discourses and practices 
to contribute to this process. The way the language and 
architecture of quality and QI tend to operate under 
managerial influence within health services can, we have 
argued, act as an obstacle to genuine broadening of clini-
cal agendas. The objects of QI are constrained by institu-
tional boundaries, making it difficult to operate with ends 
and goals that are not health-related in this constrained 
sense. This is not an inevitable problem—budgets and 
systems could be less siloed—but it is a problem in prac-
tice. Moreover, moving to partnership working which is 
supported by shared financial and institutional structures 
is liable to be very difficult and present other challenges 
[23, 49, 50].
Furthermore, the pursuit of managerial ends can fail 
to tap into clinicians’ motivation to pursue the objects 
of value that are more salient to them. The dominant 
language of healthcare QI is not very good at captur-
ing the full range of what matters to individuals as 
good outcomes—it’s much better at capturing specific 
system-level effects within certain institutional set-
tings, because it’s designed to operate at this level and 
in these settings. This seems like more of a fundamen-
tal problem that requires change in the methodological 
emphases within QI—perhaps, we suggest, via move-
ment towards models of QI that more overtly combine 
deliberative with technical thinking, including via par-
ticipatory approaches that bring diverse perspectives 
on what matters into view. This methodological reform 
would provide some room for extra-clinical and plural-
istic conceptions of quality and could, perhaps, be used 
to qualify or supplement tendencies within health ser-
vice managerialism that may otherwise inhibit or dis-
tort developments like the PSI. Without attention to 
and support for such reform, QI is likely to remain one 
of the mechanisms through which dominant health ser-
vice norms—including the extensive professional and 
institutional separation of clinical and public health 
related remits and duties—are reproduced. This effec-
tively pushes poverty ‘off limits,’ along with other legiti-
mate but metrically intangible healthcare concerns.
We suggest that one way in which clinicians can 
encourage health systems to recognise the value of 
broader social and personal goods in their decision-
making and resource allocation is to advocate for 
more deliberative and participatory models of quality 
improvement. Reclaiming QI as a tool to serve clini-
cians and patients, rather than merely managerial pur-
poses, may involve compromising on some of its value 
as a technical, quantitatively-driven decision-making 
tool. This will require reducing the emphasis within 
QI on clear, uncontested answers about the benefit or 
value of interventions, and the possibility of ranking 
or directly comparing different interventions or sys-
tems. But, at the same time, it should greatly enhance 
the capacity of QI to respond to the complex practi-
cal and ethical tensions inherent in determining what 
counts as ‘good’ healthcare. As things stand there is 
the constant risk that such ethical tensions are either 
missed altogether or unwittingly ‘settled’ by institu-
tional norms that have been insufficiently scrutinised. 
More open, deliberative conceptions of QI would also 
encourage a wider range of goods and values to be 
included in decision-making about healthcare system 
design and priority setting—a range of goods and val-
ues that more adequately reflects the multiple perspec-
tives and interests of health service stakeholders, and 
avoids artificially disconnecting healthcare institutions 
and ‘health-related’ ends from civil society and broader 
social and personal goods.
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